These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28272377)

  • 1. Spotlight on Biomimetic Systems Based on Lyotropic Liquid Crystal.
    de Souza JF; Pontes KD; Alves TF; Amaral VA; Rebelo MA; Hausen MA; Chaud MV
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28272377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cubic and hexagonal liquid crystals as drug delivery systems.
    Chen Y; Ma P; Gui S
    Biomed Res Int; 2014; 2014():815981. PubMed ID: 24995330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lyotropic liquid crystals for parenteral drug delivery.
    Chavda VP; Dawre S; Pandya A; Vora LK; Modh DH; Shah V; Dave DJ; Patravale V
    J Control Release; 2022 Sep; 349():533-549. PubMed ID: 35792188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-assembling in situ gel based on lyotropic liquid crystals containing VEGF for tissue regeneration.
    Wang B; Huang Y; Huang Z; Wang H; Chen J; Pan X; Wu C
    Acta Biomater; 2019 Nov; 99():84-99. PubMed ID: 31521813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals.
    Rajabalaya R; Musa MN; Kifli N; David SR
    Drug Des Devel Ther; 2017; 11():393-406. PubMed ID: 28243062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injectable in situ forming gel based on lyotropic liquid crystal for persistent postoperative analgesia.
    Mei L; Xie Y; Huang Y; Wang B; Chen J; Quan G; Pan X; Liu H; Wang L; Liu X; Wu C
    Acta Biomater; 2018 Feb; 67():99-110. PubMed ID: 29225151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase transition and release kinetics of polyphenols encapsulated lyotropic liquid crystals.
    Zhang H; Wang Z
    Int J Pharm; 2019 Jun; 565():283-293. PubMed ID: 31078646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oil and drug control the release rate from lyotropic liquid crystals.
    Martiel I; Baumann N; Vallooran JJ; Bergfreund J; Sagalowicz L; Mezzenga R
    J Control Release; 2015 Apr; 204():78-84. PubMed ID: 25744826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyotropic liquid crystal-based transcutaneous peptide delivery system: Evaluation of skin permeability and potential for transcutaneous vaccination.
    Kozaka S; Wakabayashi R; Kamiya N; Goto M
    Acta Biomater; 2022 Jan; 138():273-284. PubMed ID: 34774785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of Nanomedicine.
    Zhai J; Fong C; Tran N; Drummond CJ
    ACS Nano; 2019 Jun; 13(6):6178-6206. PubMed ID: 31082192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Lipid-Based Lyotropic Liquid Crystal and Effects of Guest Molecules on Its Microstructure: a Systematic Review.
    Wang X; Zhang Y; Gui S; Huang J; Cao J; Li Z; Li Q; Chu X
    AAPS PharmSciTech; 2018 Jul; 19(5):2023-2040. PubMed ID: 29869308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lyotropic liquid crystal systems in drug delivery.
    Guo C; Wang J; Cao F; Lee RJ; Zhai G
    Drug Discov Today; 2010 Dec; 15(23-24):1032-40. PubMed ID: 20934534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of β-casein stabilized lipopeptide lyotropic liquid crystal nanoparticles for delivery of doxorubicin.
    Wang D; Ma B; Wang Z; Zhao Y; Sun Y; Luan Y; Wang J
    Soft Matter; 2019 Nov; 15(44):9011-9017. PubMed ID: 31687734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid polymorphism in lyotropic liquid crystals for triggered release of bioactives.
    Garti N; Libster D; Aserin A
    Food Funct; 2012 Jul; 3(7):700-13. PubMed ID: 22592749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytantriol based smart nano-carriers for drug delivery applications.
    Akbar S; Anwar A; Ayish A; Elliott JM; Squires AM
    Eur J Pharm Sci; 2017 Apr; 101():31-42. PubMed ID: 28137471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide-sensing actuators for modulating structure in lipid-based liquid crystalline drug delivery systems.
    Liu Q; Hu J; Whittaker MR; Davis TP; Boyd BJ
    J Colloid Interface Sci; 2017 Dec; 508():517-524. PubMed ID: 28866460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cubosomes as an emerging platform for drug delivery: a review of the state of the art.
    Abourehab MAS; Ansari MJ; Singh A; Hassan A; Abdelgawad MA; Shrivastav P; Abualsoud BM; Amaral LS; Pramanik S
    J Mater Chem B; 2022 Apr; 10(15):2781-2819. PubMed ID: 35315858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and characterization of liquid crystal systems containing azelaic acid for topical delivery.
    Aytekin M; Gursoy RN; Ide S; Soylu EH; Hekimoglu S
    Drug Dev Ind Pharm; 2013 Feb; 39(2):228-39. PubMed ID: 22480294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro permeation of diclofenac salts from lyotropic liquid crystalline systems.
    Yariv D; Efrat R; Libster D; Aserin A; Garti N
    Colloids Surf B Biointerfaces; 2010 Jul; 78(2):185-92. PubMed ID: 20363601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications.
    Libster D; Aserin A; Garti N
    J Colloid Interface Sci; 2011 Apr; 356(2):375-86. PubMed ID: 21315366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.